Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Inv. presentation
Consulting agrmnt
|
|
SYNERGY PHARMACEUTICALS, INC. (SGYP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/12/2019 |
GN
| FINAL DEADLINE: Bronstein, Gewirtz & Grossman, LLC - UXIN, SGYP & MHLD |
| 03/29/2019 |
GN
| Bronstein, Gewirtz & Grossman, LLC Class Action Update - UXIN, SGYP & MHLD |
| 03/21/2019 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – SGYP |
| 03/21/2019 |
GN
| INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Class Action Against Synergy Pharmaceuticals, Inc. (SGYP) and Lead Deadline: April 12, 2019 |
| 03/14/2019 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – SGYP |
| 03/07/2019 |
GN
| Pomerantz Law Firm Announces the Filing of a Class Action on Behalf of Investors in Synergy Pharmaceuticals, Inc. – SGYP |
| 02/28/2019 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Synergy Pharmaceuticals Inc. - SGYP |
| 02/12/2019 |
GN
| SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Synergy Pharmaceuticals Inc. (SGYP) |
| 02/11/2019 |
GN
| SYNERGY PHARMACEUTICALS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that it filed a securities class action lawsuit in the United States District Court for the Eastern District of New York against Synergy Pharmaceuticals, Inc. |
| 08/31/2018 |
GN
| Market Trends Toward New Normal in Sykes Enterprises, Carnival, Covenant Transportation Group, Synergy Pharmaceuticals, Regeneron Pharmaceuticals, and Minerals Technologies — Emerging Consolidated Expectations, Analyst Ratings |
| 07/27/2018 |
GN
| Market Trends Toward New Normal in Egalet, PPG Industries, Synergy Pharmaceuticals, Equity Residential, Array BioPharma, and Holly Energy Partners — Emerging Consolidated Expectations, Analyst Ratings |
| 05/10/2018 |
BW
| Synergy Pharmaceuticals Reports First Quarter 2018 Financial Results and Business Update |
| 04/25/2018 |
BW
| Synergy Pharmaceuticals to Report First Quarter 2018 Financial Results and Host Conference Call and Webcast |
|
|